|
Video: What is a Stock Split?
|
|
Anavex Life Sciences is a clinical stage biopharmaceutical company engaged in the development of therapeutics by applying medicine to central nervous system diseases. Co.'s proprietary SIGMACEPTOR Discovery Platform produced small molecule drug candidates with certain modes of action, based on its understanding of sigma receptors. Sigma receptors may be targets for therapeutics to combat many human diseases, both of neurodegenerative nature, including Alzheimer's disease, as well as of neurodevelopmental nature, like Rett syndrome. Compounds that have been subjects of Co.'s research include the following: ANAVEX®2-73 (blarcamesine), ANAVEX®3-71, ANAVEX®1-41, and ANAVEX®1066, ANAVEX®1037. According to our Anavex Life Sciences stock split history records, Anavex Life Sciences has had 1 split. | |
|
Anavex Life Sciences (AVXL) has 1 split in our Anavex Life Sciences stock split history database. The split for AVXL took place on October 28, 2015. This was a 1 for 4
reverse split, meaning for each 4
shares of AVXL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.
When a company such as Anavex Life Sciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Anavex Life Sciences stock split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Anavex Life Sciences shares, starting with a $10,000 purchase of AVXL, presented on a split-history-adjusted basis factoring in the complete Anavex Life Sciences stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$1.56 |
|
End price/share: |
$3.80 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
143.59% |
|
Average Annual Total Return: |
9.31% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$24,349.67 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
10/28/2015 | 1 for 4
|
|
|